Additional file 1: Figures S1–S5: Figure S1. of Umbilical cord blood androgen levels and ASD-related phenotypes at 12 and 36 months in an enriched risk cohort study

Scatterplot between ln-transformed testosterone (T), androstenedione (A4), and dehydroepiandrostenedione (DHEA) levels by infant sex. Figure S2. Scatterplot between ln-transformed umbilical cord androstenedione level and total AOSI score by infant sex. Figure S3. Scatterplot between ln-transformed DHEA level and total AOSI score by infant sex. Figure S4. Scatterplot between ln-transformed androstenedione level and total SRS raw score by infant sex. Figure S5. Scatterplot between ln-transformed DHEA level and total SRS raw score by infant sex. Figure S6. Scatterplot between ln-transformed androstenedione (A4) level and total AOSI score by the older affected sibling’s sex. Figure S7. Scatterplot between ln-transformed androstenedione (A4) level and total SRS score by the older affected sibling’s sex. Figure S8. Scatterplot between ln-transformed DHEA level and total AOSI score by the older affected sibling’s sex. Figure S9. Scatterplot between ln-transformed DHEA level and total SRS raw score by the older affected sibling’s sex. Tables S1–S3: Table S1. Study characteristics comparison across two outcome measures. Table S2. Total and infant sex-stratified adjusted models of androgen levels with 12- and 36-month outcomes. Table S3. Adjusted models of androgen levels with 12- and 36-month outcomes stratified by the older affected sibling’s sex. (PDF 430 kb)